Consumer Medicine Information (CMI) in Australia has been ready for a makeover since the 1990s, even before we published the first edition of Writing About Medicines for People in 1994.
CRI has worked on over 200 public document design projects since it began as a small unit in 1985. CRI investigates practical methods and achievable standards for designing digital and paper public documents, including forms; workplace procedural notices; bills, letters, and emails sent by organizations; labels and instructions that accompany products and services; and legal and financial documents and contracts.
Never ever trust Statements of Advice in their current incarnation. If you live in Australia, reports from the hearings by the Royal Commission into Misconduct in the Banking, Superannuation and Financial Services Industry will have revealed some—but not all—of the reasons why today's SOA can't be trusted.
We were very proud to be associated with: these radically innovative and transformative regulations the code of practice that we helped industry develop in response to these changes and the [...]
Meet the Elephant in the room of the current taxation debate: taxation compliance costs Taxation compliance costs—what you and I as individual taxpayers and businesses pay to comply with our obligations as taxpayers. This cost is a constant drain on the economy and massively reduces productivity. It's sometimes called 'red tape'. Yet despite successive governments' attempts to reduce red tape, they have failed to do anything but increase taxation compliance costs.
If the draft labelling regulations proposed by TGA are implemented without major change, medicine labelling will become unusable at an acceptable level by at least 50% of literate consumers..
In Australia, where responsibility for government regulation of medicine information is in the hands of the Therapeautic Goods Administration (TGA) we are about to see bad design required by regulation.
Suddenly, the Therapeutic Goods Administration (TGA) is an expert in typography and information design. The TGA has proposed a new set of guidelines for medicine labelling, to replace the evidence-based approach in TGO69A and the ASMI Code of Practice. If implemented, the new guidelines will result in more medication errors and a gradual deterioration of medicine labelling usability in Australia.